Cambridge Investment Research Advisors »

Humacyte shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $72k 13k 5.41
2024-06-30 $53k 11k 4.81

More positions owned by Cambridge Investment Research Advisors

Apple Inc Com (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte